NICE to fast track most cost-effective treatments

10:43 EDT 17 Oct 2016 | The Pharmaceutical Journal

The National Institute for Health and Care Excellence (NICE) and NHS England have proposed changes to NICE’s drug appraisal process so that some treatments become available more quickly to patients.

Original Article: NICE to fast track most cost-effective treatments


More From BioPortfolio on "NICE to fast track most cost-effective treatments"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...